ArticleJournal for immunotherapy of cancer2025

Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancer.

Shiyu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.